These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 20575654

  • 21. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE, Botsis DS, Lambrinoudaki IV, Papagianni VD, Panoulis CP, Creatsa MG, Alexandrou AP, Augoulea AD, Dendrinos SG, Creatsas GC.
    Maturitas; 2006 Mar 20; 53(4):413-23. PubMed ID: 16140483
    [Abstract] [Full Text] [Related]

  • 22. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
    Antoniou G, Kalogirou D, Karakitsos P, Antoniou D, Kalogirou O, Giannikos L.
    Maturitas; 1997 Mar 20; 26(2):103-11. PubMed ID: 9089559
    [Abstract] [Full Text] [Related]

  • 23. Long-term transdermal estradiol therapy: effects on endometrial histology and bleeding patterns.
    Clisham PR, Cedars MI, Greendale G, Fu YS, Gambone J, Judd HL.
    Obstet Gynecol; 1992 Feb 20; 79(2):196-201. PubMed ID: 1731285
    [Abstract] [Full Text] [Related]

  • 24. [Hormone replacement therapy with a transdermal estradiol gel and oral micronized progesterone. Effect on menopausal symptoms and lipid metabolism].
    Giuliani A, Concin H, Wieser F, Boritsch J, Wilfert H, Gruber D, Urdl W.
    Wien Klin Wochenschr; 2000 Jul 28; 112(14):629-33. PubMed ID: 11008325
    [Abstract] [Full Text] [Related]

  • 25. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol.
    Johnson SR, Ettinger B, Macer JL, Ensrud KE, Quan J, Grady D.
    Obstet Gynecol; 2005 Apr 28; 105(4):779-87. PubMed ID: 15802405
    [Abstract] [Full Text] [Related]

  • 26. [A randomized case-control study on the influence of percutaneous estradiol and progestin in cyclic combined regimen on endometrium and vaginal bleeding pattern in Chinese early postmenopausal women].
    Sun A, Lin S, Wei Y.
    Zhonghua Yi Xue Za Zhi; 2001 Nov 10; 81(21):1291-4. PubMed ID: 16200718
    [Abstract] [Full Text] [Related]

  • 27. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
    Lippuner K, Haenggi W, Birkhaeuser MH, Casez JP, Jaeger P.
    J Bone Miner Res; 1997 May 10; 12(5):806-12. PubMed ID: 9144347
    [Abstract] [Full Text] [Related]

  • 28. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G, Tugrul S, Uslu H, Pekin O, Eren S.
    Arch Gynecol Obstet; 2006 Feb 10; 273(5):268-73. PubMed ID: 16315025
    [Abstract] [Full Text] [Related]

  • 29. Breast epithelial proliferation in postmenopausal women evaluated through fine-needle-aspiration cytology.
    Conner P, Skoog L, Söderqvist G.
    Climacteric; 2001 Mar 10; 4(1):7-12. PubMed ID: 11379380
    [Abstract] [Full Text] [Related]

  • 30. Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy.
    Kurdoglu M, Yildirim M, Kurdoglu Z, Erdem A, Erdem M, Bilgihan A, Goktas B.
    Gynecol Endocrinol; 2011 Aug 10; 27(8):551-7. PubMed ID: 20670096
    [Abstract] [Full Text] [Related]

  • 31. [A "no-bleeding" substitute hormone treatment with an oral microdose progesterone. A prospective multicenter study].
    Gillet JY, Faguer B, André G, Magnin G, de Lignières B, Philippe E.
    J Gynecol Obstet Biol Reprod (Paris); 1994 Aug 10; 23(4):407-12. PubMed ID: 8051369
    [Abstract] [Full Text] [Related]

  • 32. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
    Cameron ST, Glasier AF, Gebbie A, Dewart H, Baird DT.
    Maturitas; 2006 Jan 10; 53(1):19-26. PubMed ID: 16325020
    [Abstract] [Full Text] [Related]

  • 33. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR.
    Menopause; 2008 Jan 10; 15(1):94-7. PubMed ID: 17882008
    [Abstract] [Full Text] [Related]

  • 34. Use of low-dosage 17 beta-estradiol for the prevention of osteoporosis.
    Ettinger B.
    Clin Ther; 1993 Jan 10; 15(6):950-62; discussion 949. PubMed ID: 8111815
    [Abstract] [Full Text] [Related]

  • 35. Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
    Lübbert H, Nauert C.
    Maturitas; 1997 Dec 15; 28(2):117-25. PubMed ID: 9522319
    [Abstract] [Full Text] [Related]

  • 36. What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone.
    Simon JA.
    Climacteric; 2012 Apr 15; 15 Suppl 1():3-10. PubMed ID: 22432810
    [Abstract] [Full Text] [Related]

  • 37. Percutaneous estradiol gel with an intrauterine levonorgestrel releasing device or natural progesterone in hormone replacement therapy.
    Suvanto-Luukkonen E, Sundström H, Penttinen J, Läärä E, Pramila S, Kauppila A.
    Maturitas; 1997 Apr 15; 26(3):211-7. PubMed ID: 9147353
    [Abstract] [Full Text] [Related]

  • 38. Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone.
    Mueck AO.
    Climacteric; 2012 Apr 15; 15 Suppl 1():11-7. PubMed ID: 22432811
    [Abstract] [Full Text] [Related]

  • 39. Spacing-out of progestin--efficacy, tolerability and compliance of two regimens for hormonal replacement in the late postmenopause.
    Rabe T, Mueck AO, Deuringer FU, Vladescú E, Runnebaum B.
    Gynecol Endocrinol; 1997 Dec 15; 11(6):383-92. PubMed ID: 9476087
    [Abstract] [Full Text] [Related]

  • 40. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial.
    Casanova G, Spritzer PM.
    Lipids Health Dis; 2012 Oct 09; 11():133. PubMed ID: 23046709
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.